Value Star Asset Management (Hong Kong) LTD Intellia Therapeutics, Inc. Transaction History

Value Star Asset Management (Hong Kong) LTD

$31.7 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 02, 2023	BUY	$34.58 - $46.03 $205,751 - $273,878	5,950 Added 40.34%	20,700 $844,000
Q1 2023 May 08, 2023	BUY	$33.3 - $44.82 $491,174 - $661,095	14,750 New	14,750 $549,000

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.5M
Shares

$113 Million
1.28% of portfolio
Vanguard Group Inc Valley Forge, PA

10.2M
Shares

$91.7 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$86.4 Million
0.0% of portfolio
State Street Corp Boston, MA

5.21M
Shares

$46.9 Million
0.0% of portfolio
Morgan Stanley New York, NY

3.81M
Shares

$34.3 Million
0.0% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $684M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Star Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Value Star Asset Management (Hong Kong) LTD with notifications on news.

Account